Search Results - "Lennart Bohrmann"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Development of a 99mTc-labeled tetrazine for pretargeted SPECT imaging using an alendronic acid-based bone targeting model by Bohrmann, Lennart, Poulie, Christian B M, Rodríguez-Rodríguez, Cristina, Karagiozov, Stoyan, Saatchi, Katayoun, Herth, Matthias M, Häfeli, Urs O

    Published in PloS one (16-04-2024)
    “…Pretargeting, which is the separation of target accumulation and the administration of a secondary imaging agent into two sequential steps, offers the…”
    Get full text
    Journal Article
  2. 2

    Pulmonary delivery of siRNA-loaded lipid-polymer hybrid nanoparticles: Effect of nanoparticle size by Wadhwa, Abishek, Bobak, Thomas R., Bohrmann, Lennart, Geczy, Reka, Sekar, Sathiya, Sathyanarayanan, Gowtham, Kutter, Jörg P., Franzyk, Henrik, Foged, Camilla, Saatchi, Katayoun, Häfeli, Urs O.

    Published in OpenNano (01-09-2023)
    “…Nanomedicines based on nanoparticles rely both on the potency of the drug as well as the efficiency of the delivery system, for which particle size plays a…”
    Get full text
    Journal Article
  3. 3

    Aptamers used for molecular imaging and theranostics - recent developments by Bohrmann, Lennart, Burghardt, Tobias, Haynes, Charles, Saatchi, Katayoun, Häfeli, Urs O

    Published in Theranostics (01-01-2022)
    “…Aptamers are single stranded oligonucleotides that fold into three dimensional structures and are able to recognize a variety of molecular targets. Due to the…”
    Get full text
    Journal Article
  4. 4

    Radiolabeling of a polypeptide polymer for intratumoral delivery of alpha-particle emitter, 225Ac, and beta-particle emitter, 177Lu by Shalgunov, Vladimir, Engudar, Gokce, Bohrmann, Lennart, Wharton, Luke, Maskell, Keiran, Johann, Kerstin, Barz, Matthias, Schaffer, Paul, Herth, Matthias M., Radchenko, Valery

    Published in Nuclear medicine and biology (01-01-2022)
    “…Radiotherapy of cancer requires both alpha- and beta-particle emitting radionuclides, as these radionuclide types are efficient at destroying different types…”
    Get full text
    Journal Article
  5. 5

    A Novel Leu-Enkephalin Prodrug Produces Pain-Relieving and Antidepressant Effects by Hohenwarter, Lukas, Puil, Ernest, Rouhollahi, Elham, Bohrmann, Lennart, Lu, Shawna, Saatchi, Katayoun, Häfeli, Urs O., Barr, Alasdair, Böttger, Roland, Viswanadham, K.K. DurgaRao, Li, Shyh-Dar

    Published in Molecular pharmaceutics (05-02-2024)
    “…Persistent pain is a significant healthcare problem with limited treatment options. The high incidence of comorbid chronic pain and depression significantly…”
    Get full text
    Journal Article
  6. 6

    Development of a 99mTc-labeled tetrazine for pretargeted SPECT imaging using an alendronic acid-based bone targeting model by Lennart Bohrmann, Christian B M Poulie, Cristina Rodríguez-Rodríguez, Stoyan Karagiozov, Katayoun Saatchi, Matthias M Herth, Urs O Häfeli

    Published in PloS one (01-01-2024)
    “…Pretargeting, which is the separation of target accumulation and the administration of a secondary imaging agent into two sequential steps, offers the…”
    Get full text
    Journal Article
  7. 7

    Quantitative Evaluation of a Multimodal Aptamer-Targeted Long-Circulating Polymer for Tumor Targeting by Bohrmann, Lennart, Burghardt, Tobias, Rodríguez-Rodríguez, Cristina, Herth, Matthias M., Saatchi, Katayoun, Häfeli, Urs O.

    Published in ACS omega (28-03-2023)
    “…Aptamers are promising targeting agents for imaging and therapy of numerous diseases, including cancer. However, a significant shortcoming of aptamers is their…”
    Get full text
    Journal Article
  8. 8

    Radiolabeling of a polypeptide polymer for intratumoral delivery of alpha-particle emitter, 225 Ac, and beta-particle emitter, 177 Lu by Shalgunov, Vladimir, Engudar, Gokce, Bohrmann, Lennart, Wharton, Luke, Maskell, Keiran, Johann, Kerstin, Barz, Matthias, Schaffer, Paul, Herth, Matthias M, Radchenko, Valery

    Published in Nuclear medicine and biology (01-01-2022)
    “…Radiotherapy of cancer requires both alpha- and beta-particle emitting radionuclides, as these radionuclide types are efficient at destroying different types…”
    Get full text
    Journal Article